News | March 01, 2023
Vaishali Pharma receives multiple orders worth US$ 73.85 million
This order is subject to initial advance payment as per the agreed terms of the contract
This order is subject to initial advance payment as per the agreed terms of the contract
Amala Hospital partners with LifeSigns to provide revolutionary technology for the first time in the State
Twelve hospitals across India will be part of the network which will support the trial in India
Alkem has submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines.
There is a fast resurgence in the transplant activities post COVID
Data build on previously reported results from the primary endpoint of investigator-assessed radiographic progression-free survival
IAGES to focus on upskilling and adoption of advanced Minimal Access Surgery technologies in 2023
The partnership is announced at Aero India 2023, Bangalore
Themis will market this drug with the brand name REMITHEM.
To bring quality cancer treatment closer to patients, India’s leading MedTech brand is joining forces with the unique technology-led platform
Subscribe To Our Newsletter & Stay Updated
